Q32 Bio to Participate in Upcoming September Investor Conferences
Ben Wolff and Trevor Thatcher will join a Jefferies fireside chat and Lake Street 1:1 meetings as Palladyne AI seeks investor interest in its embodied AI business.
- On Monday, August 31, 2026, Palladyne AI announced that Chief Executive Officer Ben Wolff and Chief Financial Officer Trevor Thatcher will participate in two upcoming investor conferences.
- Palladyne AI is a U.S.-based technology company delivering embodied artificial intelligence and collaborative autonomy solutions designed for defense and industrial markets.
- The firm's platforms operate in complex, high-risk environments, enabling human-on-the-loop decision-making and degraded-communications resilience while incorporating advanced avionics and precision-manufactured components.
- Palladyne delivers secure, American-developed technology designed to meet stringent public-sector requirements, including data sovereignty, security, and compliance standards.
- For investor relations inquiries, contact Senior Managing Director Brian S. Siegel; media inquiries should be directed to press contact Heath Meyer.
40 Articles
40 Articles
Longeveron to Present at the H.C. Wainwright 28th Annual Global Investment Conference
MIAMI, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that it will participate in the H.C. Wainwright 28th Annual Global…
Medicenna to Present at the H.C. Wainwright 28th Annual Global Investment Conference
TORONTO and HOUSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer, autoimmune, and inflammatory diseases, announced today that Dr.…
Neurocrine Biosciences to Present at Upcoming Investor Conferences in September
SAN DIEGO, Sept. 2, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its executives will participate at the following investor conferences:
TETRA TECHNOLOGIES, INC. TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
SPRING, Texas, Sept. 2, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE: TTI) announced that Brady Murphy, Chief Executive Officer, and Kurt Hallead, Treasurer and VP of Investor Relations, will be meeting with institutional investors at the…
Coverage Details
Bias Distribution
- 68% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium























